FDA Inspection
Strides Pharma, Inc.Strides Pharma, Inc. – FDA Inspection, Dec 23, 2025
Record Details
This FDA Inspection record concerns Strides Pharma, Inc., with an inspection on December 23, 2025, issued by the New York District Office, covering medical devices & rad health.
View Company Profile
ID · c40db327-2c6a-48d8-b2ec-c2c0fac4fa86
Inspection Facts
- Inspection number
- 1292202
- FDA center
- Medical Devices & Rad Health
Other FDA inspections of Strides Pharma, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 8, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 5, 2019 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| March 16, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 4, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Strides Pharma, Inc.
- FDA Inspection 1162483 - 2022-02-08
- FDA Inspection 1103039 - 2019-08-23
- FDA Inspection 1092153 - 2019-06-05
- FDA Inspection 1009619 - 2017-03-16
- FDA Inspection 932525 - 2015-06-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.